Latest & greatest articles for elderly

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on elderly or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on elderly and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for elderly

841. Cancer and the arts: metastasis—as perceived through the ages Full Text available with Trip Pro

Cancer and the arts: metastasis—as perceived through the ages 29209528 2019 01 30 2059-7029 2 3 2017 ESMO open ESMO Open Cancer and the arts: metastasis-as perceived through the ages. e000226 10.1136/esmoopen-2017-000226 Retsas Spyros S 0000-0001-5552-8118 Formerly, Consultant Medical Oncologist and Lead Clinician, Melanoma Unit, Charing Cross Hospital Campus and Imperial College, London, England, UK. eng Journal Article 2017 07 29 England ESMO Open 101690685 2059-7029 antiquity cancer gann

2017 ESMO open

842. Correction: Improving the detection of environmental enteric dysfunction: a lactulose, rhamnose assay of intestinal permeability in children aged under 5 years exposed to poor sanitation and hygiene Full Text available with Trip Pro

Correction: Improving the detection of environmental enteric dysfunction: a lactulose, rhamnose assay of intestinal permeability in children aged under 5 years exposed to poor sanitation and hygiene [This corrects the article DOI: 10.1136/bmjgh-2016-000066.].

2017 BMJ global health

843. Postnatal gestational age estimation using newborn screening blood spots: a proposed validation protocol Full Text available with Trip Pro

Postnatal gestational age estimation using newborn screening blood spots: a proposed validation protocol Knowledge of gestational age (GA) is critical for guiding neonatal care and quantifying regional burdens of preterm birth. In settings where access to ultrasound dating is limited, postnatal estimates are frequently used despite the issues of accuracy associated with postnatal approaches. Newborn metabolic profiles are known to vary by severity of preterm birth. Recent work by our group (...) the algorithm's accuracy in small-for-gestational-age and large-for-gestational-age infants, 2) determine its ability to correctly discriminate GA of newborns across dichotomous thresholds of preterm birth (≤34 weeks, <37 weeks GA) and 3) compare the relative performance of algorithms derived from newborn screening panels including all available analytes and those restricted to analyte subsets. The study population will consist of infants born to mothers already enrolled in one of two preterm birth cohorts

2017 BMJ global health

844. A systematic review of generic and breast cancer specific life expectancy models in the elderly. (Abstract)

A systematic review of generic and breast cancer specific life expectancy models in the elderly. The use of primary endocrine therapy (PET) in managing breast cancer in the elderly has become common practice. Whilst there appears to be no difference in overall survival in comparison with surgery, PET has been found to be inferior in local disease control with a limited duration of efficacy (2-3 years). The International Society of Geriatric Oncology (SIOG) state that PET may be considered (...) elders. Accuracy (as defined by discrimination; c-statistic or AUROC) ranged from 0.69 (moderate) to 0.86 (very good).This review highlighted a variety of validated prognostic indexes. Several models with very good accuracy were identified but most were validated in US-populations and relied on information from administrative datasets. One breast specific model by Stotter et al. was identified, specifically to aid treatment planning for frail elderly patients but had limited accuracy. The strength

2017 European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

845. Fingolimod (Gilenya) oral formulation for multiple sclerosis in paediatric patients (aged 10 – 17 years)

Fingolimod (Gilenya) oral formulation for multiple sclerosis in paediatric patients (aged 10 – 17 years) Fingolimod (Gilenya) oral formulation for multiple sclerosis in paediatric patients (aged 10 – 17 years) | Innovation Observatory toggle menu Menu Search View All Filter by Speciality Filter by Year Filter by Category This search function provides links to outputs produced by NIHR Innovation Observatory. These are briefing notes or reports on new or repurposed technologies. This search (...) will not return all technologies currently in development as these outputs are produced as required for our stakeholders. > > > Fingolimod (Gilenya) oral formulation for multiple sclerosis in paediatric patients (aged 10 – 17 years) Fingolimod (Gilenya) oral formulation for multiple sclerosis in paediatric patients (aged 10 – 17 years) July 2017 The current treatment is already licensed in adults, but is currently in a phase III trial for the treatment of multiple sclerosis in paediatric patients. Fingolimod

2017 NIHR Innovation Observatory

846. Identifying characteristics and outcomes that are associated with fall-related fatalities: multi-year retrospective summary of fall deaths in older adults from 2005–2012 Full Text available with Trip Pro

injuries included younger age (OR = .91, 95% CI = .89-.94), male gender (OR = 2.5, 95% CI = 1.7-3.8), prescribed anticoagulants (OR = 2.4, 95% CI = 1.5-3.9) and negative musculoskeletal comorbidity (OR = 1.9. 95% CI = 1.1-3.0).Hip fractures and head injuries were the most common injury after a fall that led to death in older adults greater than 65 years. There are opposing risk factors for older adults who incur a hip fracture compared to a head injury. Thus, health professionals will need (...) Identifying characteristics and outcomes that are associated with fall-related fatalities: multi-year retrospective summary of fall deaths in older adults from 2005–2012 Fall-related deaths continue to be the leading cause of accidental deaths in the older adult (65+ year) population. However, many fall-related fatalities are unspecified and little is known about the fall characteristics and personal demographics at the time of the fall. Therefore, this report describes the characteristics

2017 Injury epidemiology

847. Pleomorphic rhabdomyosarcoma infiltrating thoracic spine in a 59-year-old female patient: Case report Full Text available with Trip Pro

Pleomorphic rhabdomyosarcoma infiltrating thoracic spine in a 59-year-old female patient: Case report Rhabdomyosarcoma (RMS) represents a malignant tumor of skeletal muscle cells arising from rhabdomyoblasts. RMS represents the most common soft tissue sarcoma in children. In adults it is uncommon and accounts for less than 1% of all malignant solid tumors. While treatment protocols are well known for children, there is no standardized regimen in adults. This is one reason, why the outcome (...) in adults is worse than in children. We present the case of a 59-year-old female patient with pleomorphic rhabdomyosarcoma (PRMS) infiltrating the thoracic spine. Multimodality treatment was performed including en-bloc resection, adjuvant multidrug chemotherapy and radiation beam therapy. The patient was tumor free and had no relapse within 6 month follow-up.

2017 GMS Interdisciplinary plastic and reconstructive surgery DGPW

848. Interactive Journal Club: Teaching an Old Dog New Tricks Full Text available with Trip Pro

Interactive Journal Club: Teaching an Old Dog New Tricks The interactive journal club incorporates basic principles of active and adult learning in a traditional education tool to maximize opportunity to develop critical thinking, communication skills, active reflection, and personal confidence in these skills. Following the choice of an appropriate article, the Designated Leader (DL) directs the discussion by presenting the title and data from the article with instructions for their analysis

2017 Journal of medical education and curricular development

849. Digital immunization registry: evidence for the impact of mHealth on enhancing the immunization system and improving immunization coverage for children under one year old in Vietnam Full Text available with Trip Pro

Digital immunization registry: evidence for the impact of mHealth on enhancing the immunization system and improving immunization coverage for children under one year old in Vietnam The Vietnam National Expanded Program on Immunization (NEPI) has been successfully implementing a nationwide immunization system since 1985. From the start, the program has increased the immunization coverage rate; however, data on immunization coverage in Vietnam are gathered and aggregated from commune health (...) %. For measles 1 vaccine, the rate increased from 70.4% to 76.2% to 92.3%. In addition, the dropout rate from Quinvaxem 1 to Quinvaxem 3 declined from 4.2% in 2013 to 0% in 2015, and the dropout rate from Bacillus Calmette-Guérin (BCG) to measles 1 fell from 12.8% in 2013 to 0% in 2015. Full immunization coverage of children under one year old increased significantly from 75.4% in 2013 to 81.7% in 2014 to 99.2% in 2015. Also, survey results indicated that 93.3% of interviewees were willing to pay for SMS

2017 mHealth

850. Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice Full Text available with Trip Pro

Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice 28724116 2018 11 13 2380-6591 2 9 2017 Sep 01 JAMA cardiology JAMA Cardiol Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice. 1040-1042 10.1001/jamacardio.2017.2369 Pagidipati Neha J NJ Duke Clinical Research Institute, Duke University, Durham, North Carolina. Hellkamp Anne A Duke Clinical Research

2017 JAMA cardiology

851. Association Between Structured Physical Activity and Sedentary Time in Older Adults Full Text available with Trip Pro

Jack WJ Department of Health and Exercise Science, Wake Forest University, Winston-Salem, North Carolina. Gill Thomas M TM Department of Medicine, Yale School of Medicine, New Haven, Connecticut. Glynn Nancy W NW Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania. Tudor-Locke Catrine C Department of Kinesiology, University of Massachusetts Amherst, Amherst. Manini Todd M TM Department of Aging and Geriatric Research, University of Florida, Gainesville. eng P30 AG028740 (...) Association Between Structured Physical Activity and Sedentary Time in Older Adults 28719683 2017 08 31 2018 12 02 1538-3598 318 3 2017 Jul 18 JAMA JAMA Association Between Structured Physical Activity and Sedentary Time in Older Adults. 297-299 10.1001/jama.2017.7203 Wanigatunga Amal A AA Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland. Ambrosius Walter T WT Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina. Rejeski W

2017 JAMA Controlled trial quality: uncertain

852. Experiences of substitute decision makers in making decisions for older persons diagnosed with major neurocognitive disorder at end of life: a qualitative systematic review protocol. (Abstract)

Experiences of substitute decision makers in making decisions for older persons diagnosed with major neurocognitive disorder at end of life: a qualitative systematic review protocol. The objective of this systematic review is to identify and synthesize the best available qualitative evidence on how substitute decision makers (SDMs) are affected by and experience making decisions at end of life (EOL) for older persons diagnosed with major neurocognitive disorder (major NCD) (dementia (...) ). Addressing the objective will provide an understanding of SDMs' experiences of making decisions for older persons diagnosed with major NCD at EOL, in order to tailor supportive education and interventions and potentially decrease inopportune outcomes.Specifically, the review questions are as follows.

2017 JBI database of systematic reviews and implementation reports

853. Incorporating biomarkers into the study of socio-economic status and health among older adults in China Full Text available with Trip Pro

) longevity areas sub-sample to examine the social gradient in healthamong rural young-old and oldest-old adults (N=2,121). Our health indicators include individual biomarkers, metabolic syndrome, and self-reports of health. We found a largely positive relationship between SES and health. SES was more consistently associated with individual biomarkers among the oldest-old than the young-old, providing evidence for cumulative disadvantage. We discuss the implications of our findings for older adults who (...) Incorporating biomarkers into the study of socio-economic status and health among older adults in China The social gradient in health - that individuals with lower SES have worse health than those with higher SES- is welldocumented using self-reports of health in more developed countries. Less is known about the relationship between SES and health biomarkers among older adults residing in less developed countries. We use data from the ChineseLongitudinal Healthy Longevity Survey (CLHLS

2017 SSM - population health

854. Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors Full Text available with Trip Pro

from lung adenocarcinoma patients from June 2005 to April 2014, recorded their clinical demographic data, and analysed EGFR mutations by reverse transcriptase PCR. EGFR mutation data were collected from 1039 lung adenocarcinoma patients, including 161 patients aged ≤50 years and 878 patients aged >50 years. Fewer patients aged ≤50 years had EGFR mutations than older patients (p=0.043), but they showed a higher rate of uncommon EGFR mutations (p=0.035). A total of 524 patients with EGFR mutations (...) received EGFR-TKI treatment, including 81 patients aged ≤50 years. Younger patients had a lower response rate than older patients (p=0.038) and had the shortest progression-free survival compared with other predefined age categories (p=0.033). Multivariate analysis of overall survival revealed age ≤50 years as a poor prognostic factor. In conclusion, fewer Asian patients aged ≤50 years had EGFR mutations, but the EGFR mutation types were more uncommon. Age ≤50 years is associated with poorer efficacy

2017 ERJ open research

855. Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone. Full Text available with Trip Pro

 = 433 195) of patients aged 65 years or older undergoing a health evaluation (baseline) at Swedish health care facilities; 1802 patients who were prescribed alendronate after at least 3 months of oral prednisolone treatment (≥5 mg/d) were identified. Propensity score matching was used to select 1802 patients without alendronate use from 6076 patients taking prednisolone with the same dose and treatment time criteria. Follow-up occurred between January 2008 and December 2014.Alendronate vs no alendronate (...) Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone. Oral glucocorticoid treatment increases fracture risk, and evidence is lacking regarding the efficacy of alendronate to protect against hip fracture in older patients using glucocorticoids.To investigate whether alendronate treatment in older patients using oral prednisolone is associated with decreased hip fracture risk and adverse effects.Retrospective cohort study using a national database (N

2017 JAMA

856. Immunogenicity of 2 vs 3 Doses of the Quadrivalent Human Papillomavirus Vaccine in Girls Aged 9 to 13 Years After 60 Months. Full Text available with Trip Pro

Immunogenicity of 2 vs 3 Doses of the Quadrivalent Human Papillomavirus Vaccine in Girls Aged 9 to 13 Years After 60 Months. 28444267 2017 07 06 2017 07 06 1538-3598 317 16 2017 04 25 JAMA JAMA Immunogenicity of 2 vs 3 Doses of the Quadrivalent Human Papillomavirus Vaccine in Girls Aged 9 to 13 Years After 60 Months. 1687-1688 10.1001/jama.2017.1840 Ogilvie Gina G University of British Columbia, Vancouver, British Columbia, Canada. Sauvageau Chantal C Centre Hospitalier Universitaire de Québec

2017 JAMA Controlled trial quality: uncertain

857. Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial. Full Text available with Trip Pro

Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial. Hypothermia for 72 hours at 33.5°C for neonatal hypoxic-ischemic encephalopathy reduces death or disability, but rates continue to be high.To determine if cooling for 120 hours or to a temperature of 32.0°C reduces death or disability at age 18 months in infants with hypoxic-ischemic encephalopathy.Randomized 2 × 2 factorial clinical (...) at 18 to 22 months of age adjusted for center and level of encephalopathy. Severe disability included any of Bayley Scales of Infant Development III cognitive score less than 70, Gross Motor Function Classification System (GMFCS) level of 3 to 5, or blindness or hearing loss despite amplification. Moderate disability was defined as a cognitive score of 70 to 84 and either GMFCS level 2, active seizures, or hearing with amplification.The trial was stopped for safety and futility in November 2013

2017 JAMA Controlled trial quality: predicted high

858. Aging and Emotions: Experience, Regulation, and Perception Full Text available with Trip Pro

Aging and Emotions: Experience, Regulation, and Perception Whereas some theories suggest that emotion-related processes become more positive with age, recent empirical findings on affective experience, emotion regulation, and emotion perception depict a more nuanced picture. Though there is some evidence for positive age trajectories in affective experience, results are mixed for emotion regulation and largely negative for emotion perception. Thus, current findings suggest that the effects (...) of age on emotion vary across different affective domains; age patterns are also influenced by different moderators, including contextual factors and individual differences.Copyright © 2017 Elsevier Ltd. All rights reserved.

2017 Current opinion in psychology

859. Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial Full Text available with Trip Pro

Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial We previously reported the noninferiority 1 month after the last dose of 2-dose human papillomavirus 16/18 AS04-adjuvanted (AS04-HPV-16/18) vaccine schedules at months 0 and 6 (2D_M0,6) and months 0 and 12 (2D_M0,12) in girls aged 9-14 years compared with a 3-dose schedule at months 0, 1, and 6 (3D_M0,1,6) in women aged 15-25 years. Here, we report

2017 EvidenceUpdates

860. Ideal Cardiovascular Health, Mortality, and Vascular Events in Elderly Subjects: The Three-City Study Full Text available with Trip Pro

Ideal Cardiovascular Health, Mortality, and Vascular Events in Elderly Subjects: The Three-City Study The benefit of ideal cardiovascular health (CVH) on health-related outcomes in middle-aged patients is firmly established. In the growing elderly population, the high prevalence of comorbidities and medications for chronic diseases may offset such benefit.This study analyzed the association of ideal CVH with mortality, incident coronary heart disease, and stroke events in elderly individuals (...) from the community.Between 1999 and 2001, 9,294 men and women, noninstitutionalized and aged 65 years and over were examined, and thereafter followed up for the occurrence of vascular events and mortality within the Three-City Study. Hazard ratios (HRs) were estimated by Cox proportional hazard model and compared subjects with 3 to 4 and subjects with 5 to 7 ideal metrics with those with 0 to 2 ideal metrics, respectively.The mean age was 73.8 ± 5.3 years, and 36.7% were men. Only 5

2017 EvidenceUpdates